Micrornas in body fluids as biomarkers for non-small cell lung cancer: A systematic review

Technology in Cancer Research and Treatment

Volumn 13, Issue 3, 2014, Pages 277-287

  Huang, Yuanshuai ^a   Hu, Qiongying ^a   Deng, Zhenghua ^a   Hang, Yonglun ^a   Wang, Jie ^a   Wang, Kaizheng ^a  

^a SOUTHWEST MEDICAL UNIVERSITY   (China)

Author keywords

Diagnostic; MicroRNAs; Non small cell lung cancer; Systematic review

Indexed keywords

LET 7A; MICRORNA; MICRORNA 1254; MICRORNA 21; MICRORNA 34; MICRORNA 574 5P; UNCLASSIFIED DRUG; TUMOR MARKER;

AREA UNDER THE CURVE; ARTICLE; BODY FLUID; CANCER THERAPY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; HUMAN; LUNG NON SMALL CELL CANCER; RECEIVER OPERATING CHARACTERISTIC; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; BLOOD; CARCINOMA, NON-SMALL-CELL LUNG; GENETICS; LUNG NEOPLASMS;

CARCINOMA, NON-SMALL-CELL LUNG; HUMANS; LUNG NEOPLASMS; MICRORNAS; TUMOR MARKERS, BIOLOGICAL;

EID: 84894567215     PISSN: 15330346     EISSN: None     Source Type: Journal    
DOI: 10.7785/tcrt.2012.500377     Document Type: Article

References (50)

1. Siegel, R., Naishadham, D., Jemal A. Cancer statistics, 2012. CA: A Cancer Journal for Clinicians 62, 10-29 (2012). DOI: 10.3322/ caac.20138
2. Al-Saleh, K., Quinton, C., Ellis, P. M. Role of pemetrexed in advanced non-small cell lung cancer: Meta-analysis of randomized controlled trials, with histology subgroup analysis. Current Oncology (Toronto, Ont.) 19, e9-e15 (2012). DOI: 10.3747/co.19.891
3. Indovina, P., Marcelli, E., Maranta, P., Tarro, G. Lung cancer pro-teomics: recent advances in biomarker discovery. International Journal of Proteomics (2011). DOI: 10.1155/2011/726869
4. Hennessey, P. T., Sanford, T., Choudhary, A., Mydlarz, W. W., Brown, D., Adai, A. T., Ochs, M. F., Ahrendt, S. A., Mambo, E., Califano, J. A. Serum microRNA biomarkers for detection of non-small cell lung cancer. PloS One 7, e32307 (2012). DOI: 10.1371/ journal.pone.0032307
5. Peltier, H. J., Latham, G. J. Normalization of microRNA expression levels in quantitative RT-PCR assays: identifcation of suitable reference RNA targets in normal and cancerous human solid tissues. RNA 14, 844-852 (2008). DOI: 10.1261/rna.939908
6. Vansteenkiste, J., Dooms, C., De Leyn, P. Early stage non-small-cell lung cancer: Challenges in staging and adjuvant treatment. Evidence-based staging. Annals of oncology: Offcial Journal of the European Society for Medical Oncology/ESMO 21(Suppl. 7), 189-195 (2010). DOI: 10.1093/annonc/mdq424
7. Sung, H. J., Cho, J. Y. Biomarkers for the lung cancer diagnosis and their advances in proteomics. BMB Reports 41, 615-625 (2008).
8. Patz, E. F. Jr., Campa, M. J., Gottlin, E. B., Kusmartseva, I., Guan, X. R., Herndon, J. E. 2nd. Panel of serum biomarkers for the diagnosis of lung cancer. Journal of Clinical Oncology: Offcial Journal of the American Society of Clinical Oncology 25, 5578-5583 (2007). DOI: 10.1200/jco.2007.13.5392
9. Xiao, T., Ying, W., Li, L., Hu, Z., Ma, Y., Jiao, L., Ma, J., Cai, Y., Lin, D., Guo, S., Han, N., Di, X., Li, M., Zhang, D., Su, K., Yuan, J., Zheng, H., Gao, M., He, J., Shi, S., Li, W., Xu, N., Zhang, H., Liu, Y., Zhang, K., Gao, Y., Qian, X., Cheng, S. An approach to studying lung cancer-related proteins in human blood. Molecular & Cellular Proteomics: MCP 4, 1480-1486 (2005). DOI: 10.1074/mcp. M500055-MCP200
10. Bartel, D. P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281-297 (2004).
11. Amaral, P. P., Mattick, J. S. Noncoding RNA in development. Mammalian Genome: Offcial Journal of the International Mammalian Genome Society 19, 454-492 (2008). DOI: 10.1007/s00335-008-9136-7
12. Yamashita, S., Yamamoto, H., Mimori, K., Nishida, N., Takahashi, H., Haraguchi, N., Tanaka, F., Shibata, K., Sekimoto, M., Ishii, H., Doki, Y., Mori, M. MicroRNA-372 is associated with poor prognosis in colorectal cancer. Oncology 82, 205-212 (2012). DOI: 10.1159/000336809
13. Weiland, M., Gao, X. H., Zhou, L., Mi, Q. S. Small RNAs have a large impact: circulating microRNAs as biomarkers for human diseases. RNA Biology 9, 850-859 (2012).
14. Tjensvoll, K., Svendsen, K. N., Reuben, J. M., Oltedal, S., Gilje, B., Smaaland, R., Nordgard, O. MiRNA expression profling for identif-cation of potential breast cancer biomarkers. Biomarkers 17, 463-470 (2012). DOI: 10.3109/1354750x.2012.686061
15. Markou, A., Liang, Y., Lianidou, E. Prognostic, therapeutic and diagnostic potential of microRNAs in non-small cell lung cancer. Clinical Chemistry and Laboratory Medicine: CCLM/FESCC 49, 1591-1603 (2011). DOI: 10.1515/cclm.2011.661
16. Markou, A., Sourvinou, I., Vorkas, P. A., Yousef, G. M., Lianidou, E. Clinical evaluation of microRNA expression profling in non small cell lung cancer. Lung Cancer (2013). DOI: S0169-5002(13)00219-5; PII:10.1016/j.lungcan.2013.05.007
17. Arora, S., Ranade, A. R., Tran, N. L., Nasser, S., Sridhar, S., Korn, R. L., Ross, J. T., Dhruv, H., Foss, K. M., Sibenaller, Z., Ryken, T., Gotway, M. B., Kim, S., Weiss, G. J. MicroRNA-328 is associated with (non-small) cell lung cancer (NSCLC) brain metastasis and mediates NSCLC migration. International Journal of Cancer. Journal International du Cancer 129, 2621-2631 (2011). DOI: 10.1002/ijc.25939
18. Wang, X. C., Tian, L. L., Jiang, X. Y., Wang, Y. Y., Li, D. G., She, Y., Chang, J. H., Meng, A. M. The expression and function of miRNA-451 in non-small cell lung cancer. Cancer Lett 311, 203-209 (2011). DOI: 10.1016/j.canlet.2011.07.026; PII: S0304-3835(11)00451-4
19. Whiting, P., Rutjes, A. W., Reitsma, J. B., Bossuyt, P. M., Kleijnen, J. The development of QUADAS: A tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Medical Research Methodology 3, 25 (2003). DOI: 10.1186/1471-2288-3-25
20. Whiting, P., Harbord, R., Kleijnen, J. No role for quality scores in systematic reviews of diagnostic accuracy studies. BMC Medical Research Methodology 5, 19 (2005). DOI: 10.1186/1471-2288-5-19
21. Wang, Z., He, M. L., Zhao, J. M., Qing, H. H., Wu, Y. Meta-analysis of associations of the Ezrin gene with human osteosarcoma response to chemotherapy and prognosis. Asian Pac J Cancer Prev 14, 2753-2758 (2013).
22. Tang, L., Zhao, S., Liu, W., Parchim, N. F., Huang, J., Tang, Y., Gan, P., Zhong, M. Diagnostic accuracy of circulating tumor cells detection in gastric cancer: Systematic review and meta-analysis. BMC Cancer 13, 314 (2013). DOI: 10.1186/1471-2407-13-314; PII: 1471-2407-13-314
23. Glas, A. S., Lijmer, J. G., Prins, M. H., Bonsel, G. J., Bossuyt, P. M. The diagnostic odds ratio: A single indicator of test performance. J Clin Epidemiol 56, 1129-1135 (2003). DOI: S089543560300177X [
24. Jeong, H. C., Kim, E. K., Lee, J. H., Lee, J. M., Yoo, H. N., Kim, J. K. Aberrant expression of let-7a miRNA in the blood of non-small cell lung cancer patients. Molecular Medicine Reports 4, 383-387 (2011). DOI: 10.3892/mmr.2011.430
25. Shen, J., Liu, Z., Todd, N. W., Zhang, H., Liao, J., Yu, L., Guarnera, M. A., Li, R., Cai, L., Zhan, M., Jiang, F. Diagnosis of lung cancer in individuals with solitary pulmonary nodules by plasma microRNA biomarkers. BMC Cancer 11, 374 (2011). DOI: 10.1186/1471-2407-11-374
26. Shen, J., Todd, N. W., Zhang, H., Yu, L., Lingxiao, X., Mei, Y., Guarnera, M., Liao, J., Chou, A., Lu, C. L., Jiang, Z., Fang, H., Katz, R. L., Jiang, F. Plasma microRNAs as potential biomarkers for non-small-cell lung cancer. Laboratory Investigation: A Journal of Technical Methods and Pathology 91, 579-587 (2011). DOI: 10.1038/ labinvest.2010.194; PII: labinvest2010194
27. Chen, X., Hu, Z., Wang, W., Ba, Y., Ma, L., Zhang, C., Wang, C., Ren, Z., Zhao, Y., Wu, S., Zhuang, R., Zhang, Y., Hu, H., Liu, C., Xu, L., Wang, J., Shen, H., Zhang, J., Zen, K., Zhang, C. Y. Identifca-tion of ten serum microRNAs from a genome-wide serum microRNA expression profle as novel noninvasive biomarkers for nonsmall cell lung cancer diagnosis. International Journal of Cancer. Journal International Du Cancer 130, 1620-1628 (2012). DOI: 10.1002/ijc.26177
28. Harbord, R. M., Deeks, J. J., Egger, M., Whiting, P., Sterne, J. A. A unifcation of models for meta-analysis of diagnostic accuracy studies. Biostatistics 8, 239-251 (2007). DOI: 10.1093/biostatistics/kxl004
29. Xie, Y., Todd, N. W., Liu, Z., Zhan, M., Fang, H., Peng, H., Alattar, M., Deepak, J., Stass, S. A., Jiang, F. Altered miRNA expression in sputum for diagnosis of non-small cell lung cancer. Lung Cancer 67, 170-176 (2010). DOI: 10.1016/j.lungcan.2009.04.004
30. Bianchi, F., Nicassio, F., Marzi, M., Belloni, E., Dall'Olio, V., Bernard, L., Pelosi, G., Maisonneuve, P., Veronesi, G., Di Fiore, P. P. A serum circulating miRNA diagnostic test to identify asymptomatic high-risk individuals with early stage lung cancer. EMBO Molecular Medicine 3, 495-503 (2011). DOI: 10.1002/emmm.201100154
31. Puerta-Gil, P., Garcia-Baquero, R., Jia, A. Y., Ocana, S., Alvarez-Mugica, M., Alvarez-Ossorio, J. L., Cordon-Cardo, C., Cava, F., Sanchez-Carbayo, M. miR-143, miR-222, and miR-452 are useful as tumor stratifcation and noninvasive diagnostic biomarkers for bladder cancer. The American Journal of Pathology 180, 1808-1815 (2012). DOI: 10.1016/j.ajpath.2012.01.034
32. Piepoli, A., Tavano, F., Copetti, M., Mazza, T., Palumbo, O., Panza, A., di Mola, F. F., Pazienza, V., Mazzoccoli, G., Biscaglia, G., Gentile, A., Mastrodonato, N., Carella, M., Pellegrini, F., di Sebastiano, P., Andriulli, A. Mirna expression profles identify drivers in colorectal and pancreatic cancers. PloS One 7, e33663 (2012). DOI: 10.1371/journal.pone.0033663
33. Nair, V. S., Maeda, L. S., Ioannidis, J. P. Clinical outcome prediction by microRNAs in human cancer: a systematic review. Journal of the National Cancer Institute 104, 528-540 (2012). DOI: 10.1093/jnci/ djs027
34. Fiorucci, G., Chiantore, M. V., Mangino, G., Percario, Z. A., Affabris, E., Romeo, G. Cancer regulator microRNA: Potential relevance in diagnosis, prognosis and treatment of cancer. Current Medicinal Chemistry 19, 461-474 (2012).
35. Yu, D. C., Li, Q. G., Ding, X. W., Ding, Y. T. Circulating microRNAs: Potential biomarkers for cancer. International Journal of Molecular Sciences 12, 2055-2063 (2011). DOI: 10.3390/ijms12032055
36. Lin, Q., Mao, W., Shu, Y., Lin, F., Liu, S., Shen, H., Gao, W., Li, S., Shen, D. A cluster of specifed microRNAs in peripheral blood as biomarkers for metastatic non-small-cell lung cancer by stem-loop RT-PCR. Journal of Cancer Research and Clinical Oncology 138, 85-93 (2012). DOI: 10.1007/s00432-011-1068-z
37. Zheng, D., Haddadin, S., Wang, Y., Gu, L. Q., Perry, M. C., Freter, C. E., Wang, M. X. Plasma microRNAs as novel biomarkers for early detection of lung cancer. International Journal of Clinical and Experimental Pathology 4, 575-586 (2011).
38. Du, Y., Liu, M., Gao, J., Li, Z. Aberrant microRNAs expression patterns in pancreatic cancer and their clinical translation. Cancer Biother Radiopharm 28, 361-369 (2013). DOI: 10.1089/cbr.2012.1389
39. Ali, S., Almhanna, K., Chen, W., Philip, P. A., Sarkar, F. H. Differentially expressed miRNAs in the plasma may provide a molecular signature for aggressive pancreatic cancer. Am J Transl Res 3, 28-47 (2010).
40. Wei, J., Gao, W., Zhu, C. J., Liu, Y. Q., Mei, Z., Cheng, T., Shu, Y. Q. Identifcation of plasma microRNA-21 as a biomarker for early detection and chemoSEN of non-small cell lung cancer. Chinese Journal of Cancer 30, 407-414 (2011).
41. Li, T., Li, R. S., Li, Y. H., Zhong, S., Chen, Y. Y., Zhang, C. M., Hu, M. M., Shen, Z. J. miR-21 as an independent biochemical recurrence predictor and potential therapeutic target for prostate cancer. The Journal of Urology 187, 1466-1472 (2012). DOI: 10.1016/ j.juro.2011.11.082
42. Zhang, H. L., Yang, L. F., Zhu, Y., Yao, X. D., Zhang, S. L., Dai, B., Zhu, Y. P., Shen, Y. J., Shi, G. H., Ye, D. W. Serum miRNA-21: elevated levels in patients with metastatic hormone-refractory prostate cancer and potential predictive factor for the effcacy of docetaxel-based chemotherapy. The Prostate 71, 326-331 (2011). DOI: 10.1002/pros.21246
43. Sanforenzo, C., Ilie, M. I., Belaid, A., Barlesi, F., Mouroux, J., Marquette, C. H., Brest, P., Hofman, P. Two panels of plasma microRNAs as non-invasive biomarkers for prediction of recurrence in resectable NSCLC. PloS One 8, e54596 (2013). DOI: 10.1371/ journal.pone.0054596; PII: PONE-D-12-19883
44. Kirschner, M. B., Kao, S. C., Edelman, J. J., Armstrong, N. J., Vallely, M. P., van Zandwijk, N., Reid, G. Haemolysis during sample preparation alters microRNA content of plasma. PloS One 6, e24145 (2011). DOI: 10.1371/journal.pone.0024145; PII: PONE-D-11-07207
45. Yuxia, M., Zhennan, T., Wei, Z. Circulating miR-125b is a novel bio-marker for screening non-small-cell lung cancer and predicts poor prognosis. Journal of Cancer Research and Clinical Oncology 138, 2045-2050 (2012). DOI: 10.1007/s00432-012-1285-0
46. Davoren, P. A., McNeill, R. E., Lowery, A. J., Kerin, M. J., Miller, N. Identification of suitable endogenous control genes for microRNA gene expression analysis in human breast cancer. BMC Mol Biol 9, 76 (2008). DOI: 10.1186/1471-2199-9-76; PII: 1471-2199-9-76
47. Leefang, M. M., Debets-Ossenkopp, Y. J., Visser, C. E., Scholten, R. J., Hooft, L., Bijlmer, H. A., Reitsma, J. B., Bossuyt, P. M., Vandenbroucke-Grauls, C. M. Galactomannan detection for invasive aspergillosis in immunocompromized patients. Cochrane Database of Systematic Reviews (Online), CD007394 (2008). DOI: 10.1002/14651858.cd007394
48. Foss, K. M., Sima, C., Ugolini, D., Neri, M., Allen, K. E., Weiss, G. J. miR-1254 and miR-574-5p: Serum-based microRNA biomarkers for early-stage non-small cell lung cancer. Journal of Thoracic Oncology: Offcial Publication of the International Association for the Study of Lung Cancer 6, 482-488 (2011). DOI: 10.1097/ JTO.0b013e318208c785
49. Tang, D., Shen, Y., Wang, M., Yang, R., Wang, Z., Sui, A., Jiao, W., Wang, Y. Identifcation of plasma microRNAs as novel noninvasive biomarkers for early detection of lung cancer. Eur J Cancer Prev (2013). DOI: 10.1097/CEJ.0b013e32835f3be9
50. Ulivi, P., Foschi, G., Mengozzi, M., Scarpi, E., Silvestrini, R., Amadori, D., Zoli, W. Peripheral blood miR-328 expression as a potential biomarker for the early diagnosis of NSCLC. International Journal of Molecular Sciences 14, 10332-10342 (2013). DOI: 10.3390/ijms140510332; PII: ijms140510332